Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |